← Open Payments lookup

GINELA LEININGER: Open Payments

NPI 1962079343 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,942 in 80 payments from 30 companies in 2025. Trend: 2023 $1,784 · 2024 $1,547 · 2025 $1,942

Food & beverage: $1,680Education: $262
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation14$263
Astellas Pharma US Inc4$193
Janssen Biotech, Inc.6$184
Merck Sharp & Dohme LLC7$156
Celgene Corporation5$128
AstraZeneca Pharmaceuticals LP5$109
SEAGEN INC.1$93
Incyte Corporation4$92
Exelixis Inc.4$76
Daiichi Sankyo Inc.3$69

Products named: KISQALI, KEYTRUDA, RYBREVANT, REBLOZYL, IMFINZI, CABOMETYX, OPDIVO, BRUKINSA.

Industry payments across AL — which companies pay providers there.